ACRX : Summary for AcelRx Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets open in 5 hrs 35 mins

AcelRx Pharmaceuticals, Inc. (ACRX)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.05-0.03 (-0.81%)
At close: 4:00PM EDT
People also watch
ALIMAVEOAEGRECYTINFI
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close3.08
Open3.00
Bid2.05 x 100
Ask3.60 x 500
Day's Range3.00 - 3.10
52 Week Range2.40 - 4.08
Volume97,133
Avg. Volume214,050
Market Cap138.28M
Beta2.87
PE Ratio (TTM)-3.20
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube12 hours ago

    ETFs with exposure to AcelRx Pharmaceuticals, Inc. : March 27, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to AcelRx Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ACRX-US. Comparing the performance and risk of AcelRx Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • AcelRx Pharmaceuticals, Inc. :ACRX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
    Capital Cube8 days ago

    AcelRx Pharmaceuticals, Inc. :ACRX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017

    Categories: Yahoo Finance Get free summary analysis AcelRx Pharmaceuticals, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of AcelRx Pharmaceuticals, Inc. – Pain Therapeutics, Inc., DURECT Corporation, Galena Biopharma, Inc., Medicines Company and Cara Therapeutics Inc (PTIE-US, DRRX-US, GALE-US, MDCO-US and CARA-US) that have also reported ... Read more (Read more...)

  • AcelRx Pharmaceuticals to Participate at Three Upcoming Investor Events in March and April
    PR Newswire11 days ago

    AcelRx Pharmaceuticals to Participate at Three Upcoming Investor Events in March and April

    REDWOOD CITY, Calif., March 17, 2017 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative ...